Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × pasireotide × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Peritoneal Neoplasms 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 24 Cisplatin 22 Paclitaxel 21 Oxaliplatin 16 Cytoreduction Surgical Procedures 16 Carboplatin 14 Fluorouracil 12 Doxorubicin 9 Bevacizumab 9 Mitomycin 7 Leucovorin 7 Docetaxel 6 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4 Gemcitabine 4 Blood Specimen Collection 4 130-nm albumin-bound paclitaxel 4 sodium thiosulfate 3 catumaxomab 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 Albumin-Bound Paclitaxel 3 tremelimumab 2 relacorilant 2 pembrolizumab 2 olaparib 2 nintedanib 2 liposomal doxorubicin 2 Taxes 2 Platinum 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04826432 2024-02-08

PASIREOCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Terminated

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡